Publication Type : Journal Article
Publisher : Brieflands
Source : Jundishapur Journal of Microbiology
Url : https://doi.org/10.5812/jjm.23567
Campus : Chennai
School : School of Engineering
Year : 2015
Abstract : Thrombolytic therapy has become a conventional treatment for acute myocardial infarction (AMI), yet currently, clinically prescribed thrombolytic drugs have problems such as delayed action and other side effects. Fibrinolytic enzymes have attracted interest as thrombolytic agents because of their efficiency in the fibrinolytic process, including plasmin activation. Nattokinase (NK) is a potent f ibrinolytic agent for thrombosis therapy.
Cite this Research Publication : Subathra Devi Chandrasekaran, Mohanasrinivasan Vaithilingam, Ravi Shanker, Sanjeev Kumar, Swathi Thiyur, Vaishnavi Babu, Jemimah Naine Selvakumar, Suyash Prakash, Exploring the In Vitro Thrombolytic Activity of Nattokinase From a New Strain Pseudomonas aeruginosa CMSS, Jundishapur Journal of Microbiology, Brieflands, 2015, https://doi.org/10.5812/jjm.23567